Hase T, Chargui J, Inori F, Yoshimura R, Sembeil R, Nakatani T, Touraine J L
Clinical Immunology and Transplantation Claude Bernard University, Hopital Edouard Herriot, Lyon, France.
Transplant Proc. 2005 Jan-Feb;37(1):287-8. doi: 10.1016/j.transproceed.2004.12.162.
Interleukin (IL)-10 regulates immune responses, acting as a suppressive cytokine by inhibiting the synthesis of Th1 cytokines, such as IL-2 and interferon (IFN)-gamma. It also strongly down-regulates major histocompatibility complex (MHC) class II determinants on antigen presenting cells (APC). On the other hand, long-term tolerance is well correlated with the persistence of a peripheral microchimerism. In this study, we investigated the synergistic effect of human IL-10 (huIL-10) and hematopoietic microchimerism for the induction of long-term tolerance. Irradiated Balb/c mice (H-2d) were used as recipients (fetal liver stem cells [FLSC], skin and heart) and C57BL/6 (H-2b) mice were used as donors of FLSC, skin and heart. Recipients were simultaneously transplanted with the heart, the skin and with huIL-10 gene-transduced FLSC. Microchimerism was checked using fluorescent flow cytometry, huIL10 production using enzyme-linked immunosorbent assay (ELISA), and graft survival was evaluated by daily observation. Significant level of huIL10 (up to 900 pg/mL) was detected for more than 2 weeks in the serum of mice that underwent transplantation. Four weeks after the FLSC injection, microchimerism was identified in the recipient lymphoid organs (spleen, thymus, and bone marrow) by the presence of donor cells (H-2b). Finally, in the group of mice treated with huIL-10 gene-transduced FLSC, skin allografts survived for 18.9 +/- 1.8 days compared with 9.5 and 9.6 days in the groups of mice treated with nontransduced FLSC or huIL-10 alone, respectively. The same pattern for heart allograft survival was observed. HuIL-10 transduction of donor hematopoietic stem cells resulted in production of huIL-10, cell engraftment, and chimerism. Although full tolerance was not obtained, specific and highly significant (P < .001) prolongation of the survival of donor heart allografts with (more than 2-fold compared with nontreated groups) was observed. The infiltration of the transplanted heart and its late rejection demonstrate that stem cells transduced with huIL-10 gene induce "prope" tolerance in this model.
白细胞介素(IL)-10通过抑制Th1细胞因子(如IL-2和干扰素(IFN)-γ)的合成来调节免疫反应,起到抑制性细胞因子的作用。它还能强烈下调抗原呈递细胞(APC)上的主要组织相容性复合体(MHC)II类决定簇。另一方面,长期耐受与外周微嵌合体的持续存在密切相关。在本研究中,我们研究了人IL-10(huIL-10)和造血微嵌合体对诱导长期耐受的协同作用。将经照射的Balb/c小鼠(H-2d)用作受体(胎肝干细胞[FLSC]、皮肤和心脏),C57BL/6(H-2b)小鼠用作FLSC、皮肤和心脏的供体。受体同时接受心脏、皮肤和经huIL-10基因转导的FLSC移植。使用荧光流式细胞术检查微嵌合体,使用酶联免疫吸附测定(ELISA)检测huIL-10的产生,并通过每日观察评估移植物存活情况。在接受移植的小鼠血清中,在超过2周的时间内检测到显著水平的huIL-10(高达900 pg/mL)。在注射FLSC四周后,通过供体细胞(H-2b)的存在在受体淋巴器官(脾脏、胸腺和骨髓)中鉴定出微嵌合体。最后,在用经huIL-10基因转导的FLSC治疗的小鼠组中,皮肤同种异体移植物存活了18.9±1.8天,而在用未转导的FLSC或单独的huIL-10治疗的小鼠组中分别为9.5天和9.6天。观察到心脏同种异体移植物存活的相同模式。供体造血干细胞的huIL-10转导导致huIL-10的产生、细胞植入和嵌合体形成。虽然未获得完全耐受,但观察到供体心脏同种异体移植物的存活有特异性且高度显著(P<.001)的延长(与未治疗组相比增加了2倍以上)。移植心脏的浸润及其晚期排斥反应表明,用huIL-10基因转导的干细胞在该模型中诱导了“前体”耐受。